Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 15;8(11):ofab514.
doi: 10.1093/ofid/ofab514. eCollection 2021 Nov.

Antipseudomonal Versus Narrow-Spectrum Agents for the Treatment of Community-Onset Intra-abdominal Infections

Lacy J Worden  1 , Lisa E Dumkow  1   2 , Kali M VanLangen  1   3 , Thomas S Beuschel  1 , Andrew P Jameson  1   2   4
Affiliations

Antipseudomonal Versus Narrow-Spectrum Agents for the Treatment of Community-Onset Intra-abdominal Infections

Lacy J Worden et al. Open Forum Infect Dis. .

Abstract

Background: Antipseudomonal antibiotics are often used to treat community-acquired intra-abdominal infections (CA-IAIs) despite common causative pathogens being susceptible to more narrow-spectrum agents. The purpose of this study was to compare treatment-associated complications in adult patients treated for CA-IAI with antipseudomonal versus narrow-spectrum regimens.

Methods: This retrospective cohort study included patients >18 years admitted for CA-IAI treated with antibiotics. The primary objective of this study was to compare 90-day treatment-associated complications between patients treated empirically with antipseudomonal versus narrow-spectrum regimens. Secondary objectives were to compare infection and treatment characteristics along with patient outcomes. Subgroup analyses were planned to compare outcomes of patients with low-risk and high-risk CA-IAIs and patients requiring surgical intervention versus medically managed.

Results: A total of 350 patients were included: antipseudomonal, n=204; narrow spectrum, n=146. There were no differences in 90-day treatment-associated complications between groups (antipseudomonal 15.1% vs narrow spectrum 11.3%, P=.296). In addition, no differences were observed in hospital length of stay, 90-day readmission, Clostridiodes difficile, or mortality. In multivariate logistic regression, treatment with a narrow-spectrum regimen (odds ratio [OR], 0.75; 95% confidence interval, 0.39-1.45) was not independently associated with the primary outcome. No differences were observed in 90-day treatment-associated complications for (1) patients with low-risk (antipseudomonal 15% vs narrow spectrum 9.6%, P=.154) or high-risk CA-IAI (antipseudomonal 15.8% vs narrow spectrum 22.2%, P=.588) or (2) those who were surgically (antipseudomonal 8.5% vs narrow spectrum 9.2%, P=.877) or medically managed (antipseudomonal 23.1 vs narrow spectrum 14.5, P=.178).

Conclusions: Treatment-associated complications were similar among patients treated with antipseudomonal and narrow-spectrum antibiotics. Antipseudomonal therapy is likely unnecessary for most patients with CA-IAI.

Keywords: antimicrobial resistance; antipseudomonal; appendicitis; diverticulitis; intra-abdominal infections.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flowchart summarizing patient inclusion screening, including reasons for exclusion. GI, gastrointestinal; HIV, human immunodeficiency virus; ICD, International Classification of Diseases; IV, intravenous.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sartelli M, Catena F, Abu-Zidan FM, et al. . Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference. World J Emerg Surg 2017; 12:22. - PMC - PubMed
    1. Humes DJ, Simpson J.. Acute appendicitis. BMJ 2006; 333:530–4. - PMC - PubMed
    1. Peery AF. Recent advances in diverticular disease. Curr Gastroenterol Rep 2016; 18:37. - PubMed
    1. Lodise TP, Izmailyan S, Olesky M, Lawrence K.. An evaluation of treatment patterns and associated outcomes among adult hospitalized patients with lower-risk community-acquired complicated intra-abdominal infections: how often are expert guidelines followed? Open Forum Infect Dis 2020; 7:ofaa237. - PMC - PubMed
    1. Centers for Disease Control and Prevention. Multidrug-resistant Pseudomonas aeruginosa. Available at: https://www.cdc.gov/hai/organisms/pseudomonas.html. Accessed 5 May 2021.